The concept of innovative drugs is resurfacing, Keye Technology's stock rose more than 10%

In early trading, the concept of innovative medicines is repeatedly active, Keye Technology rose more than 10%, Nanjing New Bai had two consecutive limit up, Lianhuan Pharmaceuticals, Microcore Biosciences, Ditze Medicine, Shutaishen, Kailaiying, etc. also rose.